Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
0.00%
)
US TECH 100
23,619.20
(
-0.43%
)
Dow Jones
46,021.43
(
0.00%
)
Brent Oil
104.92
(
0.46%
)
Bitcoin
70,305.99
(
0.58%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: north40000 post# 213736

Wednesday, 09/20/2017 10:38:09 AM

Wednesday, September 20, 2017 10:38:09 AM

Post# of 257262

Is the real problem that PCPs are reluctant to switch patients from a long prescribed product.../

That's an impediment to the uptake of FoBs for chronic diseases, but it's not the main impediment, IMO. Rather, the main impediment is the subject of PFE's lawsuit: the branded-drug companies' use of exclusionary contracts with PBMs and third-party payers to try to shut FoBs out of the market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now